- Europe and International + 33 1 81 69 16 01
- USA and Canada +1 617 682 3624
- Deputy CEO
Xavier Champavère holds a PhD in enzymology from the University of Compiègne (France) and a Master’s degree in pharmaceutical marketing from the Ecole supérieure de commerce in Paris. After 25 years in the international pharmaceutical industry, including work for Serono FBL and Aventis Pasteur, he is now a widely respected expert in management and entrepreneurial growth.
- Deputy CEO
Jean-Charles Epinat, PhD completed his doctoral studies in molecular and cellular genetics at the University of Paris VI after working at the Institut Pasteur on gene transcription regulation. He did his research fellowship at Boston University in the United States. Dr Epinat joined Cellectis in 2000, where he has served as Director of the Group’s high-throughput screening and nuclease production facility since 2005. Among other accomplishments, his methods for selecting and screening meganuclease activity in yeast are still used today.
- Executive VP Marketing
Luc joined Cellectis bioresearch in January 2009 bringing more than ten years of experience in R&D and Business Development. Luc holds a PhD in Pharmacology from the René Descartes University of Paris, an MSc in Plant Breeding and Genetics from the University of Illinois at Urbana-Champaign, and is a former agricultural engineer from ENSAIA of Nancy. After co-founding Hybrigenics in 1998, Luc held several positions in R&D and Business Development, where he was responsible for developing and licensing novel drug discovery technologies and the successful launch of a fee-for-service business unit in 2003. Prior to joining Cellectis bioresearch, Luc was in charge of Sales & Marketing at Hybrigenics Services, positioning the company as the leading provider of complete solutions for protein interaction studies.
Jean-Pierre has been with Cellectis since 2000, initially joining as a project leader. In October 2008 he moved to Cellectis bioresearch as Chief Operating Officer (COO). Prior to Cellectis Jean-Pierre held a five year post-doctoral fellowship at the National Cancer Institute of the NIH. During the eight years in Cellectis R&D he studied the mechanisms involved in meganuclease-mediated homologous recombination, developing and optimising the cGPS system. Jean-Pierre’s PhD in Immunology was awarded in 1994 by the Institut Pasteur, Paris.